Amgen (AMGN) rose in after-hours trading on Tuesday after the biopharmaceutical company reported second-quarter earnings that beat analysts' expectations. Amgen (AMGN) rose in after-hours trading ...

Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Multi-Factor Investor model based on the published strategy of ...

Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Multi-Factor Investor model based on the published strategy of ...

Amgen (AMGN) came out with quarterly earnings of $4.97 per share, beating the Zacks Consensus Estimate of $4.93 per share. This compares to earnings of $5 per share a year ago. These figures are ...

Amgen (NASDAQ:AMGN) traded lower on Wednesday as Wells Fargo downgraded the Dow component to Equal Weight from Overweight, arguing that the stock already reflects a potential trial success for the ...

The FTC said in its complaint that Amgen would be able to leverage its position with insurance companies and pharmacy benefit managers wanting access to its blockbuster drugs. President Biden is ...

Amgen (AMGN) reported $8.39 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 20.1%. EPS of $4.97 for the same period compares to $5.00 a year ago.

My name is Julianne, and I will be your conference facilitator today for Amgen's Second Quarter 2024 Financial Results Conference Call. All lines have been placed on mute to prevent any background ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...